// App-Quantinova.ai

Su2093 : Glucagon Like Peptide-2 Production and Sensitivity in Infants Post-Resection or Gastroschisis

Researchers

Presenter

  • Viona Lam

Principal Investigators

  • Mary Brindle

  • Dana L. Boctor

  • Bolette Hartmann

  • Laurie Wallace

  • Jennifer D. Stanger

  • Jens J. Holst

Medical Centers

  • CHIRP Program, Dept of Pediatrics Gastroenterology, Alberta Children Hospital/University of Calgary, Calgary, AB, Canada

  • Medical Physiology, the Panum Institute, University of Copenhagen, Copenhagen, Denmark

  • CHIRP Program, Dept of Surgery Pediatric, Alberta Children's Hospital/Univ Calgary, Calgary, AB, Canada

Locations

  • Canada

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

  • Genetic Disorder

Disease

  • Gastroschisis

Biomarkers

  • Glucagon-like peptide-2

Drug/Treatment

  • Intranasal glucagon

Outcome

  • N/A


Study Design

  • adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim